| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.81B | +0.4% |
| Cost of Revenue | $4.91B | +5.9% |
| Gross Profit | $902.0M | -21.6% |
| R&D Expense | $108.0M | -0.9% |
| SG&A Expense | $799.0M | +36.6% |
| Interest Expense | $269.0M | +1.9% |
| Pre-tax Income | -$277.0M | -318.1% |
| Income Tax | $109.0M | +165.9% |
| Net Income | -$386.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $670.0M | -6.0% |
| Accounts Receivable | $562.0M | -9.2% |
| Inventory | $1.57B | +6.6% |
| Current Assets | $3.00B | -0.8% |
| Total Assets | $7.38B | -1.8% |
| Current Liabilities | $1.69B | -6.5% |
| Long-term Debt | $4.10B | +1.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $264.0M | +141.7% |
| Capital Expenditures | $213.0M | -40.8% |
| Investing Cash Flow | -$206.0M | +41.6% |
| Financing Cash Flow | -$126.0M | -250.0% |
| Free Cash Flow | $51.0M | +105.1% |
| -548.8% |
| EPS (Basic) | -$2.57 | -543.1% |
| EPS (Diluted) | -$2.57 | -550.9% |
| Total Liabilities |
| $7.13B |
| +3.2% |
| Stockholders' Equity | $250.0M | -58.6% |